Realcan Pharmaceutical Group Co (SZSE:002589) Inventories, Raw Materials & Components: ¥57 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:002589 Realcan Pharmaceutical Group Co Ltd SZSE:002589
53 GF Score
Price ¥3.05
GF Value ¥2.44
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Realcan Pharmaceutical Group Co Inventories, Raw Materials & Components?

Realcan Pharmaceutical Group Co SZSE:002589 -3.17% 53 Inventories, Raw Materials & Components is ¥57 Mil as of Jun. 2026. GuruFocus rates SZSE:002589 with a GF Score™ of 53/100 and a GF Value™ of ¥2.44 (Modestly Overvalued). The stock has 9 warning signs investors should review.

Realcan Pharmaceutical Group Co's inventories, raw materials & components for the quarter that ended in Jun. 2026 was ¥57 Mil.

Realcan Pharmaceutical Group Co's quarterly raw materials declined from Dec. 2025 (¥53 Mil) to Mar. 2026 (¥0 Mil) but then increased from Mar. 2026 (¥0 Mil) to Jun. 2026 (¥57 Mil).

Realcan Pharmaceutical Group Co's annual raw materials increased from Dec. 2023 (¥84 Mil) to Dec. 2024 (¥98 Mil) but then declined from Dec. 2024 (¥98 Mil) to Dec. 2025 (¥53 Mil).

Realcan Pharmaceutical Group Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Realcan Pharmaceutical Group Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Realcan Pharmaceutical Group Co Inventories, Raw Materials & Components Chart

Realcan Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.45 83.23 84.39 97.56 53.44

Realcan Pharmaceutical Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.87 0.00 53.44 0.00 57.36
SZSE:002589
53GF Score
Realcan Pharmaceutical Group Co Ltd SZSE:002589
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Realcan Pharmaceutical Group Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ¥57 Mil mean?
Realcan Pharmaceutical Group Co (SZSE:002589) has a Inventories, Raw Materials & Components of ¥57 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Realcan Pharmaceutical Group Co and its competitors.
Is Realcan Pharmaceutical Group Co's Inventories, Raw Materials & Components too high?
Realcan Pharmaceutical Group Co's current Inventories, Raw Materials & Components is ¥57 Mil. Overall, Realcan Pharmaceutical Group Co has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Realcan Pharmaceutical Group Co's Inventories, Raw Materials & Components compare to MCK and COR?
Realcan Pharmaceutical Group Co's Inventories, Raw Materials & Components of ¥57 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Distribution company?
A good Inventories, Raw Materials & Components depends on the Medical Distribution industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Realcan Pharmaceutical Group Co and its competitors. Realcan Pharmaceutical Group Co's current Inventories, Raw Materials & Components is ¥57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Realcan Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Realcan Pharmaceutical Group Co (SZSE:002589) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥2.44, compared to a current price of ¥3.05 — trading 25% above its estimated fair value. The current Inventories, Raw Materials & Components is ¥57 Mil. Realcan Pharmaceutical Group Co's overall GF Score™ is 53/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Realcan Pharmaceutical Group Co (SZSE:002589), the current Inventories, Raw Materials & Components is ¥57 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Realcan Pharmaceutical Group Co (SZSE:002589) Overvalued in 2026?

Based on GuruFocus' analysis, Realcan Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥3.05 is trading 25% above its estimated GF Value™ of ¥2.44. GuruFocus considers Realcan Pharmaceutical Group Co to be Modestly Overvalued.

Key valuation signals for SZSE:002589:

  • Inventories, Raw Materials & Components: ¥57 Mil
  • GF Value™: ¥2.44 vs. price of ¥3.05 (25% above fair value)
  • GF Score™: 53/100 with 9 warning signs

No single metric tells the full story. See the SZSE:002589 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Realcan Pharmaceutical Group Co Business Description

Address No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.
53GF Score

Get the complete analysis for SZSE:002589

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥3.05
Price
¥2.44
GF Value